Management of lupus nephropathy.
This review is an evidence- and experience-based approach to the management of SLE, particularly its kidney manifestations. Specific protocols in substantial clinical detail are provided for management and monitoring, according to the severity of the SLE manifestations. The protocols are adapted from those used in a major SLE trial. The adaptations are based on subsequent extensive clinical use of these protocols. Also described is the concomitant use of cardio- and kidney-protective therapies to optimize patient outcomes.
Hebert
Lee A
LA
Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA. hebert.1@osu.edu
D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D008181:Lupus Nephritis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D017410:Practice Guidelines as Topic
D007166:Immunosuppressive Agents